Vitamin D Supplements: Evidence for Health Benefits in Individuals with Normal Levels
For healthy adults aged 19-75 years with normal vitamin D levels (≥50 nmol/L or ≥20 ng/mL), vitamin D supplementation above current dietary reference intakes provides no demonstrable health benefits and is not recommended. 1
Key Recommendation by Population
The 2024 Endocrine Society Clinical Practice Guideline provides clear stratification based on age and risk factors 1:
Do NOT supplement above dietary reference intakes:
- Healthy adults younger than 75 years with adequate vitamin D status - Large randomized trials (VITAL, ViDA, D2d) involving over 30,000 participants demonstrated no prevention of cancer, cardiovascular events, falls, or progression to type 2 diabetes in vitamin D-replete individuals 2
- No reduction in all-cause mortality, fractures, dementia, respiratory infections, or depression 3
DO supplement empirically (without testing):
- Children and adolescents aged 1-18 years 1
- Adults over 75 years - Very small but clinically important reduction in mortality identified in this specific age group 4
- Pregnant women - Low certainty evidence suggests possible benefits on maternal, fetal, and neonatal outcomes 4
- Adults with high-risk prediabetes - 15% reduction in diabetes progression with 3-year absolute risk reduction of 3.3%, plus 30% increased likelihood of regression to normal glucose regulation 4
Critical Evidence Synthesis
The vitamin D paradox explained: Observational studies consistently show associations between low vitamin D and numerous diseases, yet randomized trials fail to confirm benefits when supplementing vitamin D-replete individuals 2. This discordance occurs because:
- Most major trials enrolled participants with baseline 25(OH)D levels already in sufficient ranges (>50 nmol/L)
- Many participants continued their own vitamin D supplements during trials
- Observational associations reflect confounding rather than causation
- Over 60 Mendelian randomization studies (designed to minimize confounding) found mostly null effects 2
The threshold principle: Benefits are primarily observed when correcting severe deficiency (<30 nmol/L or <12 ng/mL), not when supplementing already-replete individuals 5, 2. The optimal range appears to be 20-30 ng/mL (50-75 nmol/L), with a U-shaped curve where both deficiency and excess may be harmful 6.
Dosing Recommendations When Indicated
For populations where supplementation is recommended:
- Daily dosing is strongly preferred over intermittent high doses - Higher intermittent dosing (e.g., monthly boluses) may increase falls and fractures 4
- Standard dietary reference intakes: 600 IU daily for ages ≤70 years; 800 IU daily for >70 years 3
- For prediabetes prevention: doses exceeding dietary reference intakes for at least 3 years 3
Testing Recommendations
The guideline explicitly recommends against routine 25(OH)D screening in 1:
- General healthy population
- Individuals with obesity
- Individuals with dark complexion
- Any population without established clinical indications
Rationale: No clinical trial evidence supports routine screening, no clear optimal target level exists for disease prevention in healthy populations, and baseline levels in most trials were already adequate 1.
Common Pitfalls to Avoid
Do not extrapolate skeletal benefits to extra-skeletal outcomes - The mechanisms differ (intestinal calcium absorption vs. direct tissue effects) and may require different target levels and exposure durations 4
Recognize assay variability - Inter-method differences in 25(OH)D measurement persist despite standardization efforts, complicating threshold interpretation 7
Avoid universal supplementation mentality - The shift from "the more, the better" to precision-based intervention is evidence-driven 6
Do not assume athletic performance benefits - Evidence in elite athletes shows inconsistent and often null effects on strength and performance 8
The Bottom Line for Normal Vitamin D Levels
In individuals with normal serum 25(OH)D concentrations (≥50 nmol/L), supplementation beyond dietary reference intakes does not reduce mortality, prevent cardiovascular disease, reduce cancer incidence, prevent falls or fractures, or improve other health outcomes. 5, 2, 3 The totality of evidence supports correction of deficiency rather than universal supplementation for disease prevention 2, 8.
The exception remains specific high-risk populations (age >75, pregnancy, high-risk prediabetes) where empiric supplementation is justified even without testing 1, 4.